
Home » ENHANCE BIOTECH ANNOUNCES ASSET SALE AGREEMENT WITH MOUNT COOK BIOSCIENCES
ENHANCE BIOTECH ANNOUNCES ASSET SALE AGREEMENT WITH MOUNT COOK BIOSCIENCES
May 22, 2006
Enhance Biotech, Inc., a company developing a portfolio of products focused on lifestyle drugs, announced today that it has sold its opioid Delta receptor compound portfolio to Mount Cook Biosciences Inc., a company formed and funded by Paramount Biosciences, LLC of New York.
PrimeZone
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr